Unknown PHASE4 INTERVENTIONAL 2-arm NCT01512953

Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata (GENIOUS)

Randomized Comparison of PPI Versus no PPI on Top of Standard Dose Clopidogrel Therapy in Patients Stratified Based on CYC2C19 Activity Via a Genetic Point of Care System.

Sponsor: Università degli Studi di Ferrara

Conditions Coronary Stenting

Interventions Lansoprazole

Updated 5 times since 2017 Last updated: Jan 19, 2012 Started: Jan 31, 2011 Primary completion: Aug 31, 2012 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01512953, this PHASE4 trial focuses on Coronary Stenting and remains ongoing. Sponsored by Università degli Studi di Ferrara, it has been updated 5 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Università degli Studi di Ferrara

Data source: Università degli Studi di Ferrara

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ferrara, Italy